🇺🇸 FDA
Patent

US 7326697

Methods for increasing the therapeutic response to electroconvulsive therapy

granted A61KA61K31/56A61P

Quick answer

US patent 7326697 (Methods for increasing the therapeutic response to electroconvulsive therapy) held by Corcept Therapeutics Incorporated expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/56, A61P, A61P25/00, A61P25/18